{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11166856", "DateCompleted": {"Year": "2001", "Month": "05", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "49", "Issue": "1", "PubDate": {"Year": "2001", "Month": "Jan"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "The treatment of rhinovirus infections: progress and potential.", "Pagination": {"StartPage": "1", "EndPage": "14", "MedlinePgn": "1-14"}, "Abstract": {"AbstractText": ["The common cold is an important illness both as a result of the economic impact of this common disease and because of the morbidity associated with the complications of the illness. Recent attempts to develop antiviral treatments for the common cold represent a substantial advance over previous efforts. Formidable barriers remain to be overcome, however, before any of these new products will be proven to be clinically useful. Recent advances in our understanding of the pathogenesis of common cold symptoms have provided insights into potential new targets for the treatment of this illness."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, Medical University of South Carolina, Clinical Sciences Building, Room 312, 171 Ashley Avenue, Charleston, SC 29425, USA. turnerr@musc.edu"}], "Identifier": [], "LastName": "Turner", "ForeName": "R B", "Initials": "RB"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Histamine H1 Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoxazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxadiazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrrolidinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Virus"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Proteins"}, {"RegistryNumber": "126547-89-5", "NameOfSubstance": "Intercellular Adhesion Molecule-1"}, {"RegistryNumber": "47E5O17Y3R", "NameOfSubstance": "Phenylalanine"}, {"RegistryNumber": "9H4570Q89D", "NameOfSubstance": "pleconaril"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Cysteine Endopeptidases"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "3C Viral Proteases"}, {"RegistryNumber": "HG18B9YRS7", "NameOfSubstance": "Valine"}, {"RegistryNumber": "J41CSQ7QDS", "NameOfSubstance": "Zinc"}, {"RegistryNumber": "RGE5K1Q5QW", "NameOfSubstance": "rupintrivir"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "3C Viral Proteases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Common Cold"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cysteine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Echinacea"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Histamine H1 Antagonists"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["immunology", "therapeutic use"], "DescriptorName": "Intercellular Adhesion Molecule-1"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Isoxazoles"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Oxadiazoles"}, {"QualifierName": [], "DescriptorName": "Oxazoles"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Phenylalanine"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Picornaviridae Infections"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Pyrrolidinones"}, {"QualifierName": ["antagonists & inhibitors", "immunology"], "DescriptorName": "Receptors, Virus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Rhinovirus"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Valine"}, {"QualifierName": [], "DescriptorName": "Viral Proteins"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Zinc"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abraham G., Colonno R.J. Many rhinovirus serotypes share the same cellular receptor. J. Virol. 1984;51:340\u2013345.", "ArticleIdList": ["PMC254443", "6086949"]}, {"Citation": "Akerlund A., Klint T., Olen L., Rundcrantz H. Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. J. Laryngol. Otol. 1989;103:743\u2013746.", "ArticleIdList": ["2671220"]}, {"Citation": "Al-Nakib W., Higgins P.G., Barrow I., Batstone G., Tyrrell D.A. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J. Antimicrob. Chemother. 1987;20:893\u2013901.", "ArticleIdList": ["PMC7110079", "3440773"]}, {"Citation": "Arruda E., Boyle T.R., Winther B., Pevear D.C., Gwaltney J.M., Jr., Hayden F.G. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J. Infect. Dis. 1995;171:1329\u20131333.", "ArticleIdList": ["7751712"]}, {"Citation": "Arruda E., Crump C.E., Hayden F.G. In vitro selection of human rhinovirus relatively resistant to soluble intercellular adhesion molecule-1. Antimicrob. Agents Chemother. 1994;38:66\u201370.", "ArticleIdList": ["PMC284398", "8141582"]}, {"Citation": "Arruda E., Hayden F.G. Clinical studies of antiviral agents for picornavirus infections. In: Jeffries D.J., De Clercq E., editors. Antiviral Chemotherapy. John Wiley & Sons, Ltd; New York: 1995."}, {"Citation": "Arruda E., Pitkaranta A., Witek T.J., Jr., Doyle C.A., Hayden F.G. Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol. 1997;35:2864\u20132868.", "ArticleIdList": ["PMC230076", "9350748"]}, {"Citation": "Banfi B., Maturana A., Jaconi S., Arnudeau S., Laforge T., Sinha B., Ligeti E., Demaurex N., Krause K.H. A mammalian H(+) channel generated through alternative splicing of the NADPH oxidase homolog NOH-1 [In Process Citation] Science. 2000;287:138\u2013142.", "ArticleIdList": ["10615049"]}, {"Citation": "Bardin P.G., Johnston S.L., Sanderson G., Robinson B.S., Pickett M.A., Fraenkel D.J., Holgate S.T. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am. J. Respir. Cell. Mol. Biol. 1994;10:207\u2013213.", "ArticleIdList": ["8110476"]}, {"Citation": "Bauer R., Remiger P., Jurcic K., Wagner H. Beeinflussung der Phagozytose-Aktivit\u00e4t durch Echinacea-Extrakte. Z. Phytother. 1989;10:43\u201348."}, {"Citation": "Bauer R. Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In: Wagner H., editor. Immunomodulatory Agents from Plants. Birkhauser Verlag; Basel, Switzerland: 1999. pp. 41\u201388."}, {"Citation": "Becker S., Koren H.S., Henke D.C. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am. J. Respir. Cell. Mol. Biol. 1993;8:20\u201327.", "ArticleIdList": ["8417753"]}, {"Citation": "Berkowitz R.B., Tinkelman D.G. Evaluation of oral terfenadine for treatment of the common cold. Ann. Allergy. 1991;67:593\u2013597.", "ArticleIdList": ["1750722"]}, {"Citation": "Biagioli M.C., Kaul P., Singh I., Turner R.B. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Rad. Biol. Med. 1998;26:454\u2013462.", "ArticleIdList": ["9895238"]}, {"Citation": "Blumenthal M. The complete German Commission E monographs, therapeutic guide to herbal medicines: American Botanical Council, Austin, Texas Integrative Medicine Communications, Boston, Massachusetts, 1998."}, {"Citation": "Bodinet C., Buescher N. Antiviral and immunological activity of glycoproteins from Echinaea purpurea radix. Planta. Med. 1991;57(Suppl 2):A33\u2013A34."}, {"Citation": "Brinkeborn R.M., Shah D.V., Degenring F.H. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial [In Process Citation] Phytomedicine. 1999;6:1\u20135.", "ArticleIdList": ["10228604"]}, {"Citation": "Bruder J.T., Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 1997;71:398\u2013404.", "ArticleIdList": ["PMC191064", "8985363"]}, {"Citation": "Burger R.A., Torres A.R., Warren R.P., Caldwell V.D., Hughes B.G. Echinacea-induced cytokine production by human macrophages. Int. J. Immunopharmacol. 1997;19:371\u2013379.", "ArticleIdList": ["9568541"]}, {"Citation": "Cheminat A., Zawatzky R., Becker H., Brouillard R. Caffeoyl conjugates from Echinacea species: structure and biological activity. Phytochem. 1988;27:2787\u201327494."}, {"Citation": "Choi A.M.K., Jacoby D.B. Influenza a virus induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 1992;309:327\u2013329.", "ArticleIdList": ["1516705"]}, {"Citation": "Colonno R.J., Callahan P.L., Long W.J. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J. Virol. 1986;57:7\u201312.", "ArticleIdList": ["PMC252692", "3001366"]}, {"Citation": "Cordingley M.G., Register R.B., Callahan P.L., Garsky V.M., Colonno R.J. Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J. Virol. 1989;63:5037\u20135045.", "ArticleIdList": ["PMC251164", "2555540"]}, {"Citation": "Crump C.E., Arruda E., Hayden F.G. In vitro inhibitory activity of soluble ICAM-1 for the numbered serotypes of human rhinovirus. Antiviral Chem. Chemother. 1993;4:323\u2013327."}, {"Citation": "De Flora S., Grassi C., Carati L. Attenuation of influenza-like symptomatology and improvement in cell-mediated immunity with long-term N-acetylcysteine treatment. Eur. Respir. J. 1997;10:1535\u20131541.", "ArticleIdList": ["9230243"]}, {"Citation": "Diamond L., Dockhorn R.J., Grossman J., Kisicki J.C., Posner M., Zinny M.A., Koker P., Korts D., Wecker M.T. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J. Allergy Clin. Immunol. 1995;95:1139\u20131146.", "ArticleIdList": ["7751531"]}, {"Citation": "Diana G.D., Rudewicz P., Pevear D.C., Nitz T.J., Aldous S.C., Aldous D.J., Robinson D.T., Draper T., Dutko F.J., Aldi C. Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism. J. Med. Chem. 1995;38:1355\u20131371.", "ArticleIdList": ["7731021"]}, {"Citation": "Dick E.C., Jennings L.C., Mink K.A., Wartgow C.D., Inhorn S.L. Aerosol transmission of rhinovirus colds. J. Infect. Dis. 1987;156:442\u2013448.", "ArticleIdList": ["3039011"]}, {"Citation": "Douglas R.G., Jr., Alford R.H., Cate T.R., Couch R.B. The leukocyte response during viral respiratory illness in man. Ann. Intern. Med. 1966;64:521\u2013530.", "ArticleIdList": ["4286006"]}, {"Citation": "Douglas R.M., Miles H.B., Moore B.W., Ryan P., Pinnock C.B. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob. Agents Chemother. 1987;31:1263\u20131265.", "ArticleIdList": ["PMC174915", "3307620"]}, {"Citation": "Douglass J.A., Dhami D., Gurr C.E., Bulpitt M., Shute J.K., Howarth P.H., Lindley I.J., Church M.K., Holgate S.T. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am. J. Respir. Crit. Care Med. 1994;150:1108\u20131113.", "ArticleIdList": ["7921444"]}, {"Citation": "Doyle W.J., Riker D.K., McBride T.P., Hayden F.G., Hendley J.O., Swarts J.D., Gwaltney J.M. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds. Ann. Otol. Rhinol. Laryngol. 1993;102:521\u2013527.", "ArticleIdList": ["8392820"]}, {"Citation": "Dressler W.E., Myers T., London S.J., Rankell A.S., Poetsch C.E. A system of rhinomanometry in the clinical evaluation of nasal decongestants. Ann. Otol. Rhinol. Laryngol. 1977;86:310\u2013317.", "ArticleIdList": ["68703"]}, {"Citation": "Duckhorn R., Grossman J., Posner M., Zinny M., Tinkleman D. A double-blind, placebo controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. J. Allergy Clin. Immunol. 1992;90:1076\u20131082.", "ArticleIdList": ["1460211"]}, {"Citation": "Eby G.A., Davis D.R., Halcomb W.W. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob. Agents Chemother. 1984;25:20\u201324.", "ArticleIdList": ["PMC185426", "6367635"]}, {"Citation": "Eggleston P.A., Hendley J.O., Gwaltney J.M., Jr., Eggleston A.W., Leavell B.S., Jr. Histamine in nasal secretions. Int. Arch. Allergy Appl. Immunol. 1978;57:193\u2013200.", "ArticleIdList": ["659012"]}, {"Citation": "Eggleston P.A., Hendley J.O., Gwaltney J.M., Jr. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otolaryngol. 1984;413(Suppl.):25\u201335.", "ArticleIdList": ["6099951"]}, {"Citation": "Facino R.M., Carini M., Aldini G., Saibene L., Pietta P., Mauri P. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage. Planta. Med. 1995;61:510\u2013514.", "ArticleIdList": ["8824943"]}, {"Citation": "Farr B.M., Conner E.M., Betts R.F., Oleske J., Minnefor A., Gwaltney J.M., Jr. Two randomized controlled trials of zinc gluconate, lozenge therapy of experimentally induced rhinovirus colds. Antimicrob. Agents Chemother. 1987;31:1183\u20131187.", "ArticleIdList": ["PMC174900", "2820298"]}, {"Citation": "Farr B.M., Gwaltney J.K., Jr., Hendley J.O., Hayden F.G., Naclerio R.M., McBride T., Doyle W.J., Sorrentino J.V., Riker D.K., Proud D. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J. Infect. Dis. 1990;162:1173\u20131177.", "ArticleIdList": ["2172395"]}, {"Citation": "Fiedler M.A., Wernke-Dollries K., Stark J.M. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 1995;269:L865\u2013L872.", "ArticleIdList": ["8572249"]}, {"Citation": "Fox J., Cooney M., Hall C., Foy H. Rhinoviruses in Seattle families, 1975\u20131979. Am. J. Epidemiol. 1985;122:830\u2013846.", "ArticleIdList": ["2996330"]}, {"Citation": "Fox M.P., Otto M.J., McKinlay M.A. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob. Agents Chemother. 1986;30:110\u2013116.", "ArticleIdList": ["PMC176446", "3019232"]}, {"Citation": "Gaffey M.J., Kaiser D.L., Hayden F.G. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatr. Infect. Dis. J. 1988;7:223\u2013228.", "ArticleIdList": ["2895909"]}, {"Citation": "Geist F.C., Bateman J.A., Hayden F.G. In vitro activity of zinc salts against human rhinoviruses. Antimicrob. Agents Chemother. 1987;31:622\u2013624.", "ArticleIdList": ["PMC174791", "3038000"]}, {"Citation": "Godfrey J.C., Conant Sloane B., Smith D.S., Turco J.H., Mercer N., Godfrey N.J. Zinc gluconate and the common cold: a controlled clinical study. J. Int. Med. Res. 1992;20:234\u2013246.", "ArticleIdList": ["1397668"]}, {"Citation": "Greve J.K., Forte C.P., Marlor C.W., Meyer A.M., Hoover-Litty H., Wunderlich D., McClelland A. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J. Virol. 1991;65:6015\u20136023.", "ArticleIdList": ["PMC250267", "1681115"]}, {"Citation": "Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., Kamarck M.E., McClelland A. The major human rhinovirus receptor is ICAM-1. Cell. 1989;56:839\u2013847.", "ArticleIdList": ["2538243"]}, {"Citation": "Grimm W., Muller H.H. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea, on the incidence and severity of colds and respiratory infections [In Process Citation] Am. J. Med. 1999;106:138\u2013143.", "ArticleIdList": ["10230741"]}, {"Citation": "Groarke J.M., Pevear D.C. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J. Infect. Dis. 1999;179:1538\u20131541.", "ArticleIdList": ["10228078"]}, {"Citation": "Grunberg K., Timmers M.C., Smits H.H., de Klerk E.P., Dick E.C., Spaan W.J., Hiemstra P.S., Sterk P.J. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo [see comments] Clin. Exp. Allergy. 1997;27:36\u201345.", "ArticleIdList": ["PMC7164827", "9117878"]}, {"Citation": "Gustafson M., Proud D., Hendley J.O., Hayden F.G., Gwaltney J.M., Jr. Oral prednisone therapy in experimental rhinovirus infections. J. Allergy Clin. Immunol. 1996;97:1009\u20131014.", "ArticleIdList": ["8655877"]}, {"Citation": "Gwaltney J.K., Jr., Hendley J.O., Simon G., Jordan W.S., Jr. Rhinovirus infections in an industrial population: I. The occurrence of illness. New Engl. J. Med. 1966;275:1261\u20131268.", "ArticleIdList": ["4288780"]}, {"Citation": "Gwaltney J.M., Jr., Druce H.M. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin. Infect. Dis. 1997;25:1188\u20131194.", "ArticleIdList": ["9402380"]}, {"Citation": "Gwaltney J.M., Jr., Park J., Paul R.A., Edelman D.A., O'Connor R.R., Turner R.B. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin. Infect. Dis. 1996;22:656\u2013662.", "ArticleIdList": ["8729205"]}, {"Citation": "Gwaltney J.M., Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J. Infect. Dis. 1992;166:776\u2013782.", "ArticleIdList": ["1326582"]}, {"Citation": "Gwaltney J.M., Jr., Hendley J.O., Simon G., Jordan W.S., Jr. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. J. Am. Med. Assoc. 1967;202:494\u2013500.", "ArticleIdList": ["4293015"]}, {"Citation": "Gwaltney J.M., Jr., Moskalski P.B., Hendley J.O. Hand-to-hand transmission of rhinovirus colds. Ann. Intern. Med. 1978;88:463\u2013467.", "ArticleIdList": ["205151"]}, {"Citation": "Hayden F.G., Diamond L., Wood P.B., Korts D.C., Wecker M.T. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo controlled trial. Ann. Intern. Med. 1996;125:89\u201397.", "ArticleIdList": ["8678385"]}, {"Citation": "Hayden F.G., Gwaltney J.M., Jr., Colonno R.J. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res. 1988;9:233\u2013247.", "ArticleIdList": ["2849376"]}, {"Citation": "Hayden F.G., Hassman H.A., Coats T., Menendez R., Bock T. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology; San Francisco: 1999. Pleconaril treatment shortens the duration of picornavirus respiratory illness in adults."}, {"Citation": "Heinz B.A., Rueckert R.R., Shepard D.A., Dutko F.J., McKinlay M.A., Fancher M., Rossmann M.G., Badger J., Smith T.J. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 1989;63:2476\u20132485.", "ArticleIdList": ["PMC250706", "2542566"]}, {"Citation": "Hendley J.O. Rhinovirus colds: immunology and pathogenesis. Eur. J. Respir. Dis. 1983;64:340\u2013343.", "ArticleIdList": ["6311604"]}, {"Citation": "Henneicke-von Zepelin H., Hentschel C., Schnitker J., Kohnen R., Kohler G., Wustenberg P. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study. Curr. Med. Res. Opin. 1999;15:214\u2013227.", "ArticleIdList": ["10621929"]}, {"Citation": "Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., Blaas D. Members of the low density lipoprotein receptor family mediate cell entry of a minorgroup common cold virus. Proc. Natl. Acad. Sci. USA. 1994;91:1839\u20131842.", "ArticleIdList": ["PMC43259", "8127891"]}, {"Citation": "Hoheisel O., Sandberg M., Bertram S., Bulitta M., Schafer M. Echinagard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur. J. Clin. Res. 1997;9:261\u2013268."}, {"Citation": "Huguenel E.D., Cohn D., Dockum D.P., Greve J.M., Fournel M.A., Hammond L., Irwin R., Mahoney J., McClelland A., Muchmore E., Ohlin A.C., Scuderi P. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am. J. Respir. Crit. Care. Med. 1997;155:1206\u20131210.", "ArticleIdList": ["9105055"]}, {"Citation": "Igarashi Y., Skoner D.P., Doyle W.J., White M.V., Fireman P., Kaliner M.A. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J. Allergy Clin. Immunol. 1993;92:722\u2013731.", "ArticleIdList": ["8227864"]}, {"Citation": "Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A. Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children. Br. Med. J. 1995;310:1225\u20131229. [see comments]", "ArticleIdList": ["PMC2549614", "7767192"]}, {"Citation": "Kaul P., Biagioli M.C., Singh I., Turner R.B. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J. Infect. Dis. 2000;181:1885\u20131890.", "ArticleIdList": ["PMC7109975", "10837166"]}, {"Citation": "Kaul P., Biagioli M.C., Turner R.B., Singh I. Association of alterations in cellular redox pathways with rhinovirus-induced interleukin-8 elaboration. Pediatr. Res. 1997;41(part 2):123A. Abstract #722."}, {"Citation": "Kaul P., Singh I., Turner R.B. Effect of nitric oxide on rhinovirus replication and virus-induced interleukin-8 elaboration. Am. J. Respir. Crit. Care. Med. 1999;159:1193\u20131198.", "ArticleIdList": ["10194165"]}, {"Citation": "Kemper K.J. Family medicine clinic survey on the treatment of upper respiratory tract infections [letter] Arch. Fam. Med. 1998;7:517\u2013518.", "ArticleIdList": ["9821825"]}, {"Citation": "Kim J., Sanders S.P., Siekierski E.S., Casolaro V., Proud D. Role of NF-kappaB in cytokine production induced from human airway epithelial cells by rhinovirus infection [In Process Citation] J. Immunol. 2000;165:3384\u20133392.", "ArticleIdList": ["10975857"]}, {"Citation": "Knobil K., Choi A.M., Weigand G.W., Jacoby D.B. Role of oxidants in influenza virus-induced gene expression. Am. J. Physiol. 1998;274(Part 1):L134\u2013L142.", "ArticleIdList": ["9458811"]}, {"Citation": "Kogan M.D., Pappas G., Yu S.M., Kotelchuck M. Over-the-counter medication use among US preschool-age children. J. Am. Med. Assoc. 1994;272:1025\u20131030.", "ArticleIdList": ["8089884"]}, {"Citation": "Korant B.D., Kauer J.C., Butterworth B.E. Zinc ions inhibit replication of rhinoviruses. Nature (London) 1974;248:588\u2013590.", "ArticleIdList": ["4363085"]}, {"Citation": "Luettig B., Steinmuller C., Gifford G.E., Wagner H., Lohmann-Matthes M.L. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J. Natl. Cancer Inst. 1989;81:669\u2013675.", "ArticleIdList": ["2785214"]}, {"Citation": "Macknin M.L., Piedmonte M., Calendine C., Janosky J., Wald E. Zinc gluconate lozenges for treating the common cold in children. J. Am. Med. Assoc. 1998;279:1962\u20131967.", "ArticleIdList": ["9643859"]}, {"Citation": "Macknin M.L. Zinc lozenges for the common cold. Cleve. Clin. J. Med. 1999;66:27\u201332.", "ArticleIdList": ["9926628"]}, {"Citation": "Marlin S.D., Staunton D.E., Springer T.A., Stratowa C., Sommergruber W., Merluzzi V.J. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature. 1990;344:70\u201372.", "ArticleIdList": ["1968231"]}, {"Citation": "Marlovits T.C., Abrahamsberg C., Blaas D. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J. Virol. 1998;72:10246\u201310250.", "ArticleIdList": ["PMC110607", "9811769"]}, {"Citation": "Marlovits T.C., Zechmeister T., Gruenberger M., Ronacher B., Schwihla H., Blaas D. Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro. Faseb. J. 1998;12:695\u2013703.", "ArticleIdList": ["9619448"]}, {"Citation": "Marlovits T.C., Zechmeister T., Schwihla H., Ronacher B., Blaas D. Recombinant soluble low-density lipoprotein receptor fragment inhibits common cold infection. J. Mol. Recognit. 1998;11:49\u201351.", "ArticleIdList": ["10076805"]}, {"Citation": "Mastronarde J.G., He B., Monick M.M., Mukaida N., Matsushima K., Hunninghake G.W. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-\u03ba\u03b2 and NF-IL-6. J. Infect. Dis. 1996;174:262\u2013267.", "ArticleIdList": ["8699053"]}, {"Citation": "Mastronarde J.G., Monick M.M., Hunninghake G.W. Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncytial virus. Am. J. Respir. Cell. Mol. Biol. 1995;13:237\u2013244.", "ArticleIdList": ["7626291"]}, {"Citation": "Matthews D.A., Dragovich P.S., Webber S.E., Fuhrman S.A., Patick A.K., Zalman L.S., Hendrickson T.F., Love R.A., Prins T.J., Marakovits J.T., Zhou R., Tikhe J., Ford C.E., Meador J.W., Ferre R.A., Brown E.L., Binford S.L., Brothers M.A., DeLisle D.K., Worland S.T. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA. 1999;96:11000\u201311007.", "ArticleIdList": ["PMC34232", "10500114"]}, {"Citation": "Melchart D., Linde K., Worku F., Bauer R., Wagner H. Immunomodulation with Echinacea \u2014 a systematic review of controlled clinical trials. Phytomedicine. 1994;1:245\u2013254.", "ArticleIdList": ["23195946"]}, {"Citation": "Melchart D., Walther E., Linde K., Brandmaier R., Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch. Fam. Med. 1998;7:541\u2013545.", "ArticleIdList": ["9821828"]}, {"Citation": "Monto A.S., Cavallaro J.J. The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogensm 1965\u20131969. Am. J. Epidemiol. 1971;94:280\u2013289.", "ArticleIdList": ["4328569"]}, {"Citation": "Mossad S.B., Macknin M.L., Medendorp S.V., Mason P. Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study. Ann. Intern. Med. 1996;125:81\u201388.", "ArticleIdList": ["8678384"]}, {"Citation": "Mukaida N., Okamoto S., Ishikawa Y., Matsushima K. Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 1994;56:554\u2013558.", "ArticleIdList": ["7525815"]}, {"Citation": "Muller-Jakic B., Breu W., Probstle A., Redl K., Greger H., Bauer R. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea, and Achillea species. Planta. Med. 1994;60:37\u201340.", "ArticleIdList": ["8134414"]}, {"Citation": "Naclerio R.M., Proud D., Lichtenstein L.M., Kagey-Sobotka A., Hendley J.O., Sorentino J., Gwaltney J.M., Jr. Kinins are generated during experimental rhinovirus colds. J. Infect. Dis. 1988;157:133\u2013142.", "ArticleIdList": ["2447198"]}, {"Citation": "Ninomiya Y., Ohsawa C., Aoyama M., Umeda I., Suhara Y., Ishitsuka H. Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation. Virology. 1984;134:269\u2013276.", "ArticleIdList": ["6100571"]}, {"Citation": "Noah T.L., Henderson F.W., Wortman I.A., Devlin R.B., Handy J., Koren H.S., Becker S. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 1995;171:584\u2013592.", "ArticleIdList": ["7876605"]}, {"Citation": "Ohlin A., Hoover-Litty H., Sanderson G., Paessens A., Johnston S.L., Holgate S.T., Huguenel E., Greve J.M. Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates. Antimicrob. Agents Chemother. 1994;38:1413\u20131415.", "ArticleIdList": ["PMC188221", "7916557"]}, {"Citation": "Olson N.H., Kolatkar P.R., Oliveira M.A., Cheng R.H., Greve J.M., McClelland A., Baker T.S., Rossmann M.G. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA. 1993;90:507\u2013511.", "ArticleIdList": ["PMC45692", "8093643"]}, {"Citation": "Papi A., Papadopoulos N.G., Degitz K., Holgate S.T., Johnston S.L. Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells. J. Allergy Clin. Immunol. 2000;105:318\u2013326.", "ArticleIdList": ["10669853"]}, {"Citation": "Patick A.K., Binford S.L., Brothers M.A., Jackson R.L., Ford C.E., Diem M.D., Maldonado F., Dragovich P.S., Zhou R., Prins T.J., Fuhrman S.A., Meador J.W., Zalman L.S., Matthews D.A., Worland S.T. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 1999;43:2444\u20132450.", "ArticleIdList": ["PMC89498", "10508022"]}, {"Citation": "Pevear D.C., Fancher M.J., Felock P.J., Rossmann M.G., Miller M.S., Diana G., Treasurywala A.M., McKinlay M.A., Dutko F.J. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 1989;63:2002\u20132007.", "ArticleIdList": ["PMC250615", "2539499"]}, {"Citation": "Pitkaranta A., Wecker M.T., Korts D.C., Hayden F.G. Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection. Am. J. Rhinol. 1998;12:125\u2013129.", "ArticleIdList": ["9578931"]}, {"Citation": "Prasad A.S., Fitzgerald J.T., Bao B., Beck F.W., Chandrasekar P.H. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2000;133:245\u2013252.", "ArticleIdList": ["10929163"]}, {"Citation": "Puhakka T., Makela M.J., Malmstrom K., Uhari M., Savolainen J., Terho E.O., Pulkkinen M., Ruuskanen O. The common cold: effects of intranasal fluticasone propionate treatment. J. Allergy Clin. Immunol. 1998;101:726\u2013731.", "ArticleIdList": ["9648698"]}, {"Citation": "Randall J.E., Hendley J.O. A decongestant\u2013antihistaniine mixture in the prevention of otitis media in children with colds. Pediatr. 1979;63:483\u2013485.", "ArticleIdList": ["440849"]}, {"Citation": "Rossmann M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.J., Johnson J.E., Kamer G., Luo M., Mosser A.G. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985;317:145\u2013153.", "ArticleIdList": ["2993920"]}, {"Citation": "Sanders S.P., Siekierski E.S., Porter J.D., Richards S.M., Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 1998;72:934\u2013942.", "ArticleIdList": ["PMC124563", "9444985"]}, {"Citation": "Schiff G.M., Sherwood J.R. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J. Infect. Dis. 2000;181:20\u201326.", "ArticleIdList": ["10608746"]}, {"Citation": "Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-\u03ba\u03b2. Chem. Biol. 1995;2:13\u201322.", "ArticleIdList": ["9383399"]}, {"Citation": "Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-\u03ba\u03b2 transcription factor and HIV-1. EMBO. J. 1991;10:2247\u20132258.", "ArticleIdList": ["PMC452914", "2065663"]}, {"Citation": "Schroth M.K., Grimm E., Frindt P., Galagan D.M., Konno S.I., Love R., Gern J.E. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 1999;20:1220\u20131228.", "ArticleIdList": ["10340941"]}, {"Citation": "See D.M., Broumand N., Sahl L., Tilles J.G. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology. 1997;35:229\u2013235.", "ArticleIdList": ["9043936"]}, {"Citation": "Shepard D.A., Heinz B.A., Rueckert R.R. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J. Virol. 1993;67:2245\u20132254.", "ArticleIdList": ["PMC240355", "8383239"]}, {"Citation": "Simon H.K., Weinkle D.A. Over-the-counter medications. Do parents give what they intend to give? Arch. Pediatr. Adolesc. Med. 1997;151:654\u2013656. [see comments]", "ArticleIdList": ["9232037"]}, {"Citation": "Smith D.S., Helzner E.C., Nuttall C.E., Jr., Collins M., Rofman B.A., Ginsberg D., Goswick C.B., Magner A. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob. Agents Chemother. 1989;33:646\u2013648.", "ArticleIdList": ["PMC172506", "2665639"]}, {"Citation": "Smith M.B.H., Feldman W. Over-the-counter cold medications. A critical review of clinical trials between and 1950 and 1991. J. Am. Med. Assoc. 1993;269:2258\u20132263.", "ArticleIdList": ["8097268"]}, {"Citation": "Smith T.J., Kremer M.J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M.G., McKinlay M.A., Diana G.D., Otto M.J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233:1286\u20131293.", "ArticleIdList": ["3018924"]}, {"Citation": "Sperber S.J., Hayden F.G. Protective effect of rhinovirus receptor blocking antibody in human fibroblast cells. Antiviral Res. 1989;12:231\u2013238.", "ArticleIdList": ["2561332"]}, {"Citation": "Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Marlin S.D., Springer T.A. A cell adhesion molecule, ICAM-1 is the major surface receptor for rhinoviruses. Cell. 1989;56:849\u2013853.", "ArticleIdList": ["2538244"]}, {"Citation": "Stimpel M., Proksch A., Wagner H., Lohmann-Matthes M.L. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infect. Immun. 1984;46:845\u2013849.", "ArticleIdList": ["PMC261624", "6389368"]}, {"Citation": "Subauste M.C., Jacoby D.B., Richards S.M., Proud D. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 1995;96:549\u2013557.", "ArticleIdList": ["PMC185229", "7615827"]}, {"Citation": "Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 1999;401:79\u201382.", "ArticleIdList": ["10485709"]}, {"Citation": "Taverner D., Danz C., Economos D. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clin. Otolaryngol. 1999;24:47\u201351.", "ArticleIdList": ["10196648"]}, {"Citation": "Turner R.B., Cetnarowski W.E., 2000. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds, Clin. Infect. Dis. (in press).", "ArticleIdList": ["11073753"]}, {"Citation": "Turner R.B., Darden P.M. Effect of topical adrenergic decongestants on middle ear pressure in infants with common colds. Pediatr. Infect. Dis. J. 1996;15:621\u2013624.", "ArticleIdList": ["8823858"]}, {"Citation": "Turner R.B., Hendley J.O., Gwaltney J.M., Jr. Shedding of infected ciliated epithelial cells in rhinovirus colds. J. Infect. Dis. 1982;145:849\u2013853.", "ArticleIdList": ["6282984"]}, {"Citation": "Turner R.B., Riker D.K., Gangemi J.D. Ineffectiveness of echinacea for prevention of experimental rhinovirus colds. Antimicrob. Agents Chemother. 2000;44:1708\u20131709.", "ArticleIdList": ["PMC89939", "10817735"]}, {"Citation": "Turner R.B., Sperber S.J., Sorrentino J.V., O'Connor R.R., Rogers J., Batouli A.R., Gwaltney J.M., Jr. Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin. Infect. Dis. 1997;25:824\u2013830.", "ArticleIdList": ["9356796"]}, {"Citation": "Turner R.B., Wecker M.T., Pohl G., Witek T.J., McNally E., St. George R., Winther B., Hayden F.G. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection. J. Am. Med. Assoc. 1999;281:1797\u20131804.", "ArticleIdList": ["10340366"]}, {"Citation": "Turner R.B., Weingand K.W., Yeh C.-H., Leedy D. Association between nasal secretion interleukin-8 concentration and symptom severity in experimental rhinovirus colds. Clin. Infect. Dis. 1998;26:840\u2013846.", "ArticleIdList": ["9564459"]}, {"Citation": "Turner R.B., Witek T.J., Jr., Riker D.K. Comparison of symptom severity in natural and experimentally induced colds. Am. J. Rhinol. 1996;10:167\u2013172."}, {"Citation": "Turner R.B. Rhinovirus infection of human embryonic lung fibroblasts induces the production of a chemoattractant for polymorphonuclear leukocytes. J. Infect. Dis. 1988;157:346\u2013350.", "ArticleIdList": ["PMC7110071", "2826615"]}, {"Citation": "Tyrrell D.A., Cohen S., Schlarb J.E. Signs and symptoms in common colds. Epidemiol. Infect. 1993;111:143\u2013156.", "ArticleIdList": ["PMC2271186", "8394240"]}, {"Citation": "Weismann K., Jakobsen J.P., Weismann J.E., Hammer U.M., Nyholm S.M., Hansen B., Lomholt K.E., Schmidt K. Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan. Med. Bull. 1990;37:279\u2013281.", "ArticleIdList": ["2192839"]}, {"Citation": "Winther B., Brofeldt S., Christensen B., Mygind N. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol. (Stockh) 1984;97:309\u2013318.", "ArticleIdList": ["6720308"]}, {"Citation": "Winther B., Farr B., Turner R.B., Hendley J.O., Gwaltney J.M., Jr., Mygind N. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol. (Stockh) 1984;suppl 413:19\u201324.", "ArticleIdList": ["6099950"]}, {"Citation": "Winther B., Gwaltney J.M., Jr., Hendley J.O. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am. Rev. Respir. Dis. 1990;141:839\u2013845.", "ArticleIdList": ["2158258"]}, {"Citation": "Winther B., Gwaltney J.M., Jr., Mygind N., Turner R.B., Hendley J.O. Sites of rhinovirus recovery after point inoculation of the upper airway. J. Am. Med. Assoc. 1986;256:1763\u20131767.", "ArticleIdList": ["3018306"]}, {"Citation": "Yasin S.R., al-Nakib W., Tyrrell D.A. Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410. Antimicrob. Agents Chemother. 1990;34:963\u2013966.", "ArticleIdList": ["PMC171738", "2168152"]}, {"Citation": "Zalman L.S., Brothers M.A., Dragovich P.S., Zhou R., Prins T.J., Worland S.T., Patick A.K. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 2000;44:1236\u20131241.", "ArticleIdList": ["PMC89850", "10770757"]}, {"Citation": "Zhu Z., Tang W., Gwaltney J.M., Jr., Wu Y., Elias J.A. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am. J. Physiol. 1997;273:L814\u2013L824.", "ArticleIdList": ["9357857"]}]}], "History": [{"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "5", "Day": "22", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "2", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11166856", "PMC7125581", "10.1016/s0166-3542(00)00135-2", "S0166-3542(00)00135-2"]}}], "PubmedBookArticle": []}